04/19/2024
6:50 AM | Ayala Pharmaceuticals (Filer)
| Form 8-K/A | |
04/16/2024
3:11 PM | Ayala Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/15/2024
3:33 PM | Ayala Pharmaceuticals (Filer)
| Form S-8 POS | |
04/15/2024
3:33 PM | Ayala Pharmaceuticals (Filer)
| Form S-8 POS | |
04/15/2024
3:34 PM | Ayala Pharmaceuticals (Filer)
| Form S-8 POS | |
04/15/2024
3:34 PM | Ayala Pharmaceuticals (Filer)
| Form S-8 POS | |
04/15/2024
3:30 PM | Ayala Pharmaceuticals (Filer)
| Form S-8 POS | |
|
04/15/2024
3:31 PM | Ayala Pharmaceuticals (Filer)
| Form S-8 POS | |
04/15/2024
3:31 PM | Ayala Pharmaceuticals (Filer)
| Form S-8 POS | |
04/15/2024
3:32 PM | Ayala Pharmaceuticals (Filer)
| Form S-8 POS | |
04/15/2024
3:32 PM | Ayala Pharmaceuticals (Filer)
| Form S-8 POS | |
04/03/2024
4:01 PM | Ayala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
3:31 PM | Ayala Pharmaceuticals (Filer)
| Form NT 10-K | |
03/29/2024
4:06 PM | Ayala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
6:13 AM | Ayala Pharmaceuticals (Issuer)
I.B.F. Management Ltd. (Reporting)
Israel Biotech Fund GP Partners II, L.P. (Reporting)
Israel Biotech Fund GP Partners, L.P. (Reporting)
Israel Biotech Fund I, L.P. (Reporting)
Israel Biotech Fund II, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:16 AM | Ayala Pharmaceuticals (Filer)
| Form DEFM14C | |
02/20/2024
4:22 PM | Ayala Pharmaceuticals (Filer)
| Form PREM14C | |
02/12/2024
1:16 PM | Ayala Pharmaceuticals (Issuer)
I.B.F. Management Ltd. (Reporting)
Israel Biotech Fund GP Partners II, L.P. (Reporting)
Israel Biotech Fund GP Partners, L.P. (Reporting)
Israel Biotech Fund I, L.P. (Reporting)
Israel Biotech Fund II, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
10:58 AM | Ayala Pharmaceuticals (Subject)
Israel Biotech Fund I, L.P. (Filed by)
| Form SC 13D/A | |
02/12/2024
7:27 AM | Ayala Pharmaceuticals (Subject)
Schindel Yair Chaim (Filed by)
| Form SC 13G/A | |
02/09/2024
4:15 PM | Ayala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2024
7:51 AM | Ayala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
8:00 AM | Ayala Pharmaceuticals (Subject)
Israel Biotech Fund I, L.P. (Filed by)
| Form SC 13D/A | |
11/21/2023
8:04 AM | Ayala Pharmaceuticals (Issuer)
I.B.F. Management Ltd. (Reporting)
Israel Biotech Fund GP Partners II, L.P. (Reporting)
Israel Biotech Fund GP Partners, L.P. (Reporting)
Israel Biotech Fund I, L.P. (Reporting)
Israel Biotech Fund II, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
8:00 AM | Ayala Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/15/2023
3:04 PM | Ayala Pharmaceuticals (Filer)
| Form NT 10-Q | |
11/03/2023
10:43 AM | Ayala Pharmaceuticals (Issuer)
Martell Bridget A (Reporting)
| Form 3/A | |
11/03/2023
10:45 AM | Ayala Pharmaceuticals (Issuer)
Orbach Pini (Reporting)
| Form 3/A | |
11/03/2023
10:46 AM | Ayala Pharmaceuticals (Issuer)
Golan Roy (Reporting)
| Form 3/A | |
10/31/2023
6:05 AM | Ayala Pharmaceuticals (Subject)
Israel Biotech Fund I, L.P. (Filed by)
| Form SC 13D/A | |
10/31/2023
6:08 AM | Ayala Pharmaceuticals (Issuer)
I.B.F. Management Ltd. (Reporting)
Israel Biotech Fund GP Partners II, L.P. (Reporting)
Israel Biotech Fund GP Partners, L.P. (Reporting)
Israel Biotech Fund I, L.P. (Reporting)
Israel Biotech Fund II, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
5:43 AM | aMoon Growth Fund Limited Partnership (Reporting)
Ayala Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
5:45 AM | Ayala Pharmaceuticals (Subject)
Schindel Yair Chaim (Filed by)
| Form SC 13G/A | |
10/20/2023
3:31 PM | Ayala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2023
5:10 AM | Ayala Pharmaceuticals (Issuer)
I.B.F. Management Ltd. (Reporting)
Israel Biotech Fund GP Partners, L.P. (Reporting)
Israel Biotech Fund I, L.P. (Reporting)
| Form 3/A | |
09/29/2023
5:13 AM | Ayala Pharmaceuticals (Issuer)
I.B.F. Management Ltd. (Reporting)
Israel Biotech Fund GP Partners II, L.P. (Reporting)
Israel Biotech Fund GP Partners, L.P. (Reporting)
Israel Biotech Fund I, L.P. (Reporting)
Israel Biotech Fund II, L.P. (Reporting)
| Form 4/A | |
09/21/2023
3:05 PM | Ayala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
11:44 AM | Ayala Pharmaceuticals (Issuer)
Israel Biotech Fund I, L.P. (Reporting)
Israel Biotech Fund II, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
11:38 AM | Ayala Pharmaceuticals (Subject)
Israel Biotech Fund I, L.P. (Filed by)
| Form SC 13D | |
09/11/2023
11:41 AM | Ayala Pharmaceuticals (Issuer)
Israel Biotech Fund I, L.P. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/01/2023
8:00 AM | Ayala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
READ THIS – If You Missed Out On The AI Boom (Ad) Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy.
Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.” Click on Adam's shiny forehead for more details. |
06/23/2023
11:35 AM | Ayala Pharmaceuticals (Filer)
| Form DEF 14A | |
05/23/2023
12:10 PM | Ayala Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
